A Phase 1 Trial of BTM-3566 in Advanced Solid Tumors
Latest Information Update: 22 Dec 2025
At a glance
- Drugs BTM-3566 (Primary)
- Indications Solid tumours
- Focus Adverse reactions
- Sponsors Bantam Pharmaceutical
Most Recent Events
- 17 Dec 2025 Status changed from not yet recruiting to recruiting.
- 16 Dec 2025 New trial record